Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 pol replication capacity predicts disease progression.

Eric S Daar1, Karen L Kesler, Terri Wrin

  • 1Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center and the David Geffen School of Medicine at UCLA, Torrance, California 90502, USA. EDaar@LABioMed.org

AIDS (London, England)
|May 21, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bigger isn't always scarier: Aneurysm size and illness perception in thoracic aortic aneurysm patients undergoing surveillance.

Vascular medicine (London, England)·2026
Same author

Sex-Related Outcome After Sutureless Aortic Valve Replacement With Perceval Plus: Results From a Global Registry and Meta-Regression.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19.

Pathogens & immunity·2026
Same author

Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution.

Microbiology spectrum·2026
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

HIV-1 pol replication capacity impacts disease progression. Higher capacity predicts faster CD4 T-cell decline and AIDS progression in individuals with hemophilia.

Area of Science:

  • Virology
  • Immunology
  • Hematology

Background:

  • The natural history of Human Immunodeficiency Virus type 1 (HIV-1) infection is influenced by viral factors.
  • Understanding how viral replication capacity affects disease progression is crucial for managing HIV-1 in vulnerable populations like those with hemophilia.

Purpose of the Study:

  • To investigate the relationship between pol replication capacity and the clinical course of HIV-1 infection in children and adolescents with hemophilia.
  • To determine if pol replication capacity is an independent predictor of disease progression.

Main Methods:

  • Utilized a recombinant virus single-cycle assay to measure pol replication capacity in baseline plasma samples from the Hemophilia Growth and Development Study.
  • Enrolled 207 HIV-1-infected hemophiliacs aged 6-19 years between 1989-1990, with follow-up through 1997.

Related Experiment Videos

  • Employed univariate, random effects, Cox proportional hazards, and Kaplan-Meier models to analyze the association between pol replication capacity, viral load, CD4 T-cell counts, and clinical outcomes.

    • Main Results:

    • Pol replication capacity showed significant correlations with baseline HIV-1 RNA levels (R=0.189, P=0.03) and CD4 T-cell counts (r=-0.197, P=0.03).
    • Pol replication capacity independently predicted CD4 T-cell decline over time.
    • Higher pol replication capacity was associated with an increased risk of progression to Acquired Immunodeficiency Syndrome (AIDS).

    Conclusions:

    • Pol replication capacity is a significant independent factor influencing the natural history of HIV-1 infection.
    • These findings highlight the importance of viral replication capacity as a prognostic marker in HIV-1-infected individuals, particularly those with hemophilia.